The Soluble Form of IL-1 Receptor Accessory Protein Enhances the Ability of Soluble Type II IL-1 Receptor to Inhibit IL-1 Action

Immunity

Volumn 18, Issue 1, 2003, Pages 87-96

  Smith, Dirk E ^a   Hanna, Roberta ^a   Friend, Della ^a   Moore, Heather ^a   Chen, Hongbo ^a   Farese, Ann M ^b   MacVittie, Thomas J ^b   Virca, G Duke ^a   Sims, John E ^a  

^a AMGEN INC   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; RECEPTOR PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; MONKEY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM;

EID: 0037237908     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(02)00514-9     Document Type: Article

References (24)

1. Baum P.R., Gayle R.B. 3rd, Ramsdell F., Srinivasan S., Sorensen R.A., Watson M.L., Seldin M.F., Baker E., Sutherland G.R., Clifford K.N.et al. Molecular characterization of murine and human OX40/OX40 ligand systems. identification of a human OX40 ligand as the HTLV-1-regulated protein gp34 EMBO J. 13:1994;3992-4001.
2. Burger D., Chicheportiche R., Giri J.G., Dayer J.M. The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor. J. Clin. Invest. 96:1995;38-41.
3. Colotta F., Re F., Muzio M., Bertini R., Polentarutti N., Sironi M., Giri J.G., Dower S.K., Sims J.E., Mantovani A. Interleukin-1 type II receptor. a decoy target for IL-1 that is regulated by IL-4 Science. 261:1993;472-475.
4. Dayer J.M., Feige U., Edwards C.K. 3rd, Burger D. Anti-interleukin-1 therapy in rheumatic diseases. Curr. Opin. Rheumatol. 13:2001;170-176.
5. Dinarello C.A. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int. Rev. Immunol. 16:1998;457-499.
6. Durie F.H., Fava R.A., Foy T.M., Aruffo A., Ledbetter J.A., Noelle R.J. Prevention of collagen induced arthritis with an antibody to gp39, the ligand for CD40. Science. 261:1993;1328-1330.
7. Eastgate J.A., Symons J.A., Wood N.C., Grinlinton F.M., di Giovine F.S., Duff G.W. Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet. 2:1988;706-709.
8. Eisenberg S.P., Evans R.J., Arend W.P., Verderber E., Brewer M.T., Hannum C.H., Thompson R.C. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature. 343:1990;341-346.
9. Giri J.G., Wells J., Dower S.K., McCall C.E., Guzman R.N., Slack J., Bird T.A., Shanebeck K., Grabstein K.H., Sims J.E.et al. Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses. J. Immunol. 153:1994;5802-5809.
10. Greenfeder S.A., Nunes P., Kwee L., Labow M., Chizzonite R.A., Ju G. Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J. Biol. Chem. 270:1995;13757-13765.
11. Hannum C.H., Wilcox C.J., Arend W.P., Joslin F.G., Dripps D.J., Heimdal P.L., Armes L.G., Sommer A., Eisenberg S.P., Thompson R.C. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature. 343:1990;336-340.
12. Jensen L.E., Muzio M., Mantovani A., Whitehead A.S. IL-1 signaling cascade in liver cells and the involvement of a soluble form of the IL-1 receptor accessory protein. J. Immunol. 164:2000;5277-5286.
13. Jouvenne P., Vannier E., Dinarello C.A., Miossec P. Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis. correlations with markers of inflammation and joint destruction Arthritis Rheum. 41:1998;1083-1089.
14. Lang D., Knop J., Wesche H., Raffetseder U., Kurrle R., Boraschi D., Martin M.U. The type II IL-1 receptor interacts with the IL-1 receptor accessory protein. a novel mechanism of regulation of IL-1 responsiveness J. Immunol. 161:1998;6871-6877.
15. Malinowsky D., Lundkvist J., Laye S., Bartfai T. Interleukin-1 receptor accessory protein interacts with the type II interleukin-1 receptor. FEBS Lett. 429:1998;299-302.
16. Mantovani A., Locati M., Vecchi A., Sozzani S., Allavena P. Decoy receptors. a strategy to regulate inflammatory cytokines and chemokines Trends Immunol. 22:2001;328-336.
17. McMahan C.J., Slack J.L., Mosley B., Cosman D., Lupton S.D., Brunton L.L., Grubin C.E., Wignall J.M., Jenkins N.A., Brannan C.I.et al. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 10:1991;2821-2832.
18. Mohler K.M., Sleath P.R., Fitzner J.N., Cerretti D.P., Alderson M., Kerwar S.S., Torrance D.S., Otten-Evans C., Greenstreet T., Weerawarna K.et al. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature. 370:1994;218-220.
19. Mullberg J., Rauch C.T., Wolfson M.F., Castner B., Fitzner J.N., Otten-Evans C., Mohler K.M., Cosman D., Black R.A. Further evidence for a common mechanism for shedding of cell surface proteins. FEBS Lett. 401:1997;235-238.
20. Orlando S., Sironi M., Bianchi G., Drummond A.H., Boraschi D., Yabes D., Mantovani A. Role of metalloproteases in the release of the IL-1 type II decoy receptor. J. Biol. Chem. 272:1997;31764-31769.
21. Sivakumar P.V., Westrich G.M., Kanaly S., Garka K., Born T.L., Derry J.M.J., Viney J.L. Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis. blocking Interleukin 18 attenuates intestinal damage Gut. 50:2002;812-820.
22. Smith D.E., Ketchem R.R., Moore H., Anderson Z., Renshaw B.R., Friend D., Sims J.E. A single amino acid difference between human and monkey IL-1β dictates effective binding to soluble type II IL-1 receptor. J. Biol. Chem. 277:2002;47619-47625.
23. Totsuka K., Takakura H., Hashimoto O., Tatsumi M. Molecular cloning and expression of cynomolgus monkey interleukin-1beta cDNA. Int. Arch. Allergy Immunol. 116:1998;40-48.
24. Villinger F., Brar S.S., Mayne A., Chikkala N., Ansari A.A. Comparative sequence analysis of cytokine genes from human and nonhuman primates. J. Immunol. 155:1995;3946-3954.